Legend Biotech Corp - COMMON STOCK (LEGN)

Historical Holders from Q2 2020 to Q4 2025

Symbol
LEGN on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
367,291,225
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
83,665,729
Holdings value
$2,727,251,108
% of all portfolios
0%
Number of holders
197
Number of buys
108
Number of sells
89
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Legend Biotech Corp - COMMON STOCK (LEGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +7.9% $1,796,605,025 +$133,409,532 55,093,684 +8% FMR LLC 30 Sep 2025
PRICE T ROWE ASSOCIATES INC /MD/ 3.7% $217,856,736 6,808,023 T. Rowe Price Associates, Inc. 31 Dec 2024
As of 30 Sep 2025 Legend Biotech Corp - COMMON STOCK (LEGN) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,665,729 shares of 367,291,225 outstanding shares and own 23% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Legend Biotech Corp - COMMON STOCK (LEGN) own 20% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
FMR LLC 7.5% 27,702,842 +7.9% 0.05% $903,389,672
WESTFIELD CAPITAL MANAGEMENT CO LP 1.7% 6,094,486 -5.8% 0.83% $198,741,180
HHLR ADVISORS, LTD. 1.6% 5,984,550 0% 4.8% $195,156,176
BlackRock, Inc. 1.2% 4,494,623 +5.8% 0% $146,569,648
SUVRETTA CAPITAL MANAGEMENT, LLC 1% 3,818,009 +1.2% 3.8% $124,505,273
DEERFIELD MANAGEMENT COMPANY, L.P. 0.81% 2,962,338 0% 1.5% $96,601,842
Artisan Partners Limited Partnership 0.69% 2,547,952 +20% 0.12% $83,088,715
JANUS HENDERSON GROUP PLC 0.58% 2,125,085 +1.5% 0.03% $69,293,319
BRAIDWELL LP 0.5% 1,826,155 -28% 1.8% $59,550,915
ALLIANCEBERNSTEIN L.P. 0.44% 1,632,967 +4.6% 0.02% $53,251,054
STATE STREET CORP 0.32% 1,157,122 +3.3% 0% $37,733,748
FEDERATED HERMES, INC. 0.29% 1,065,303 +0.15% 0.06% $34,739,531
GOLDMAN SACHS GROUP INC 0.29% 1,055,486 +12% 0% $34,419,398
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 0.28% 1,028,447 -20% 7.8% $33,537,657
UBS Group AG 0.28% 1,010,859 -1% 0.01% $32,964,113
Capital International Investors 0.26% 941,600 -13% 0% $30,705,576
ArrowMark Colorado Holdings LLC 0.26% 938,678 -4.6% 0.57% $30,610,290
IvyRock Asset Management (HK) Ltd 0.23% 856,900 -1.5% 12% $27,943,509
RENAISSANCE TECHNOLOGIES LLC 0.23% 843,200 +28% 0.04% $27,496,752
TANG CAPITAL MANAGEMENT LLC 0.23% 830,000 0% 1% $27,066,300
JOHNSON & JOHNSON 0.22% 814,586 0% 5.3% $26,563,649
MILLENNIUM MANAGEMENT LLC 0.22% 792,485 +7% 0.02% $25,842,936
TWO SIGMA ADVISERS, LP 0.2% 723,700 +1.1% 0.05% $23,599,857
AMERIPRISE FINANCIAL INC 0.15% 542,322 -14% 0% $17,685,120
GEODE CAPITAL MANAGEMENT, LLC 0.15% 540,042 +14% 0% $17,462,097

Institutional Holders of Legend Biotech Corp - COMMON STOCK (LEGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 207 $4,500 -$289,252 $21.74 2
2025 Q3 83,665,729 $2,727,251,108 -$49,105,294 $32.61 197
2025 Q2 84,637,633 $3,002,800,929 -$25,701,884 $35.49 209
2025 Q1 85,578,048 $2,906,133,230 -$451,299,000 $33.93 204
2024 Q4 99,259,008 $3,230,144,724 +$188,312,025 $32.54 205
2024 Q3 91,083,902 $4,438,353,833 +$35,189,489 $48.73 205
2024 Q2 91,692,639 $4,060,935,512 +$155,890,330 $44.29 173
2024 Q1 86,589,839 $4,856,625,239 +$56,736,404 $56.09 193
2023 Q4 213,087 $12,808,554 +$5,351,181 $60.17 5
2023 Q3 85,954,370 $5,773,082,951 +$91,357,326 $67.17 196
2023 Q2 84,054,542 $5,802,225,306 +$1,141,637,401 $69.03 191
2023 Q1 68,016,389 $3,279,296,495 +$194,852,240 $48.22 157
2022 Q4 63,479,784 $3,168,770,467 -$29,964,838 $49.92 164
2022 Q3 63,406,174 $2,586,863,834 +$395,485,107 $40.80 151
2022 Q2 52,424,985 $2,882,767,418 +$117,157,835 $55.00 145
2022 Q1 51,000,301 $1,853,430,157 +$18,305,235 $36.34 135
2021 Q4 50,104,606 $2,335,822,768 +$497,850,700 $46.61 136
2021 Q3 39,005,864 $1,971,658,000 +$572,565,487 $50.56 89
2021 Q2 28,328,633 $1,162,840,000 +$121,637,303 $41.05 86
2021 Q1 26,391,107 $765,866,420 +$33,796,376 $29.02 70
2020 Q4 23,662,888 $666,395,000 +$18,173,638 $28.16 57
2020 Q3 24,479,702 $752,680,000 -$30,045,246 $30.87 50
2020 Q2 24,612,390 $1,036,061,000 +$1,036,060,984 $42.56 75